Rhythm Pharmaceuticals held its Annual Meeting of Stockholders on September 18, 2024, where 85.6% of eligible votes were cast, resulting in the election of three directors and the approval of key proposals including the appointment of Ernst & Young as auditors and the advisory compensation of executives.